| Pharmaceutical active ingredients: |
| Norfloxacin |
| Available forms, composition and doses of Norfloxinor: |
| N / A |
| Norfloxinor medical category: |
| Human:Ear anti-infectives and antisepticsEye anti-infectives and antisepticsQuinolones |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J01MA06 - NorfloxacinS01AX12 - Norfloxacin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Upha Corporation |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Neo-Deca | Dexamethasone Sodium Phosphate; Neomycin Sulfate | Upha Corporation; Beacons Pharmaceuticals; CCM Pharmaceuticals |
| Neo-Hydro | Hydrocortisone Acetate; Neomycin Sulfate | Upha Corporation; Beacons Pharmaceuticals; G. Streuli |
| Neomycin | Neomycin Sulfate | Upha Corporation |
| Nicol | Chloramphenicol | Upha Corporation; CCM Pharmaceuticals |
| Norethisterone | Norethindrone | Upha Corporation |
| Omesec | Omeprazole | Upha Corporation; CCM Pharmaceuticals; F.P. Marketing |
| Perinace | Perindopril Erbumine | Upha Corporation; CCM Pharmaceuticals |
| Pilo | Pilocarpine Hydrochloride | Upha Corporation |
| Pocin G | Gramicidin; Neomycin Sulfate; Polymyxin B Sulfate | Upha Corporation |
| Pocin H | Hydrocortisone; Neomycin Sulfate; Polymyxin B Sulfate | Upha Corporation; CCM Pharmaceuticals |